Vanguard Health Care Fund... (VGHAX)
NASDAQ: VGHAX
· Real-Time Price · USD
74.14
1.03 (1.41%)
At close: Apr 21, 2025, 9:30 AM
1.41% (1D)
Bid | - |
Market Cap | 34.3B |
AUM | 36B |
NAV | 73.11 |
EPS (ttm) | 4.25 |
PE Ratio (ttm) | 17.46 |
Shares Out | 462.6M |
Inception Date | Nov 12, 2001 |
Ask | - |
Volume | 0 |
Open | 74.14 |
Previous Close | 73.11 |
Day's Range | 74.14 - 74.14 |
52-Week Range | 69.01 - 100.47 |
Holdings | 85 |
Expense Ratio | 0.32% |
About VGHAX
For more than 25 years, this actively managed fund has offered investors low-cost exposure to domestic and foreign companies involved in various aspects of the health care industry, such as pharmaceutical firms, medical supply companies, and research firms. The fund tends to be more geographically diverse and exhibit lower turnover than other health care funds. Still, one risk to note is the fund’s narrow scope, investing solely within the health care sector. Returns may vary widely from year to year, so this fund should be considered complementary to a diversified portfolio with a long-term time horizon.
Asset Class Health
Ticker Symbol VGHAX
Inception Date Nov 12, 2001
Provider Vanguard
Website Fund Home Page
Exchange NASDAQ
Top 10 Holdings 44.38% of assets
Name | Symbol | Weight |
---|---|---|
Eli Lilly And Compan... | LLY | 10.37% |
Astrazeneca Plc | AZN.L | 6.25% |
Unitedhealth Group I... | UNH | 5.35% |
Merck & Co., Inc. | MRK | 4.35% |
Boston Scientific Co... | BSX | 4.18% |
Vertex Pharmaceutica... | VRTX | 3.51% |
Intuitive Surgical, ... | ISRG | 2.69% |
Danaher Corporation | DHR | 2.66% |
Novo Nordisk A/s | NOVOB.CO | 2.56% |
Abbott Laboratories | ABT | 2.46% |
Dividends Dividend Yield 1.01%
Ex-Dividend | Amount | Payment Date |
---|---|---|
Mar 28, 2025 | $0.0200 | Mar 31, 2025 |